Business Wire

Idriverplus Building Smart Autonomous Vehicles With Velodyne Lidar Technology

Share

Velodyne Lidar, Inc. today announced that Idriverplus, one of the first companies in China to launch the commercialization of driverless technology and realize mass production, is using Velodyne’s groundbreaking lidar sensors in a range of autonomous driving products. Velodyne has strategically teamed with Idriverplus to help Idriverplus with its efforts for mass production of commercial autonomous vehicles, which include street cleaners, passenger cars, and logistics vehicles.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190709005210/en/

“We have a vision for the future that autonomous driving is not only a means of transportation, but also a necessity of life,” said Idriverplus CEO Dr. Zhang Dezhao. (Photo: Business Wire)

“We have a vision for the future that autonomous driving is not only a means of transportation, but also a necessity of life,” said Idriverplus CEO Dr. Zhang Dezhao. (Photo: Business Wire)

Velodyne lidar sensors are being used in all Idriverplus self-driving vehicles, providing rich computer perception data that allows real-time object and free space detection needed for safe navigation and reliable operation.

“We have a vision for the future that autonomous driving is not only a means of transportation, but also a necessity of life,” said Idriverplus CEO Dr. Zhang Dezhao. “Lidar is indispensable in our development of autonomous driving technology. Velodyne Lidar’s products have better performance and stability in practical use, and their accuracy addresses our demanding requirements.”

The Idriverplus street cleaning vehicle, called Viggo, is an unmanned, purely electric solution to intelligently sweep roads. During the cleaning process, Viggo can automatically track and avoid obstacles with stable and reliable performance and monitor real-time vehicle information. More than 100 units are in operation in universities, factories, parks, an amusement park and city streets with deployments in Beijing, Tianjin, Shanghai, Hebei, Zhejiang, Henan, Hunan and other provinces and cities. Idriverplus also has strategic cooperation partnerships in Singapore, Dubai, Malaysia, and other areas in Asia.

Idriverplus is developing two commercial autonomous car solutions; an SAE Level 4 vehicle that provides autonomous driving in closed parks and some public roads, and an advanced driver assistance system (ADAS) solution for automatic parking (AVP) and highway follow-up (HWP). Its WOBIDA product applies self-driving technology to the logistics industry, providing a safer and better distribution experience. Idriverplus’ driverless vehicles have accumulated test mileage exceeding 400,000 kilometers, far surpassing other domestic autonomous vehicle manufacturers.

“Idriverplus is trailblazing the commercialization of driverless technology in China,” said Wei Weng, Executive Director APAC, Velodyne Lidar. “Idriverplus autonomous driving products show how Velodyne intelligent lidar sensors are enabling companies to place autonomous vehicles on the road today. They are transforming multiple service sectors by creating powerful autonomous driving solutions.”

About Velodyne Lidar

Velodyne provides smart, powerful lidar solutions for autonomy and driver assistance. Founded in 1983 and headquartered in San Jose, Calif., Velodyne is known worldwide for its portfolio of breakthrough lidar sensor technologies. In 2005, Velodyne’s Founder and CEO, David Hall, invented real-time surround view lidar systems, revolutionizing perception and autonomy for automotive, new mobility, mapping, robotics, and security. Velodyne’s high-performance product line includes a broad range of sensing solutions, including the cost-effective Puck™, the versatile Ultra Puck™, the autonomy-advancing Alpha Puck™, the ADAS-optimized Velarray™, and the groundbreaking software for driver assistance, Vella™.

Contact information

Sean Dowdall
Landis Communications Inc. for Velodyne Lidar, Inc.
(415) 286-7121
velodyne@landispr.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Vertex Confirms Wales Offer Accepted for Access to All Licensed Cystic Fibrosis Medicines13.11.2019 11:29:00 CETPress release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today confirms that NHS Wales has accepted an offer for all currently licensed Vertex cystic fibrosis (CF) medicines and any future indications of these medicines under the same terms as the recently announced agreement with NHS England. This means that once the contract is finalized, patients with CF in Wales ages 2 years and older who have two copies of the F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene can access ORKAMBI ® (lumacaftor/ivacaftor) and CF patients ages 12 years and older who either have two copies of the F508del mutation or one copy of the F508del mutation and a copy of one of the other 14 licensed mutations can access SYMKEVI® (tezacaftor/ivacaftor) in combination with ivacaftor in the coming weeks. The agreement also offers expanded access to KALYDECO ® (ivacaftor) to include those patients ages 12 months and older who have one of the nine licensed gating mutations. “Today’s a

Software Testing and Digital Transformation Partners Recognized at 2019 Tricentis Partner Awards13.11.2019 11:00:00 CETPress release

Tricentis, the cloud’s #1 Continuous Testing Platform, today recognized top-performing partners from around the world during Tricentis Accelerate 2019 in Vienna, Austria. In its 5th year, the Tricentis Partner Awards recognize organizations for accelerating digital transformation across the enterprise. Award winners were selected from more than 300 different partners worldwide based on their collaboration with Tricentis, customers, and their advocacy for Tricentis’ automation methodologies. “Tricentis partners are leading the way for organizations to innovate faster, reduce business risk, and optimize cost,” said Alan Ota, Senior Vice President of Strategic Alliances, Tricentis. “Our partners are instrumental to our business and are focused on delivering the best in-class testing solutions to our joint customers. Our tremendous growth would not be possible without our global partners. We’re proud to acknowledge the achievements made by our partners in 2019 and look forward to continuin

Applicaster Appoints Jason Johns as Vice President of Sales, EMEA and APAC13.11.2019 10:00:00 CETPress release

Applicaster, the company simplifying the lifecycle management of direct-to-consumer media applications, today announced the appointment of Jason Johns as Vice President of Sales, EMEA and APAC. In his role, Johns will oversee Applicaster’s EMEA and APAC commercial and go-to-market strategies. “There is an incredible amount of opportunity in the media app market,” said Johns. “Because of our ability to enable frictionless growth for customers, we’re very well positioned to take advantage of this opportunity. Beyond the market opportunity, I was attracted to Applicaster because of the company’s customer-first culture plus its ability and desire to drive value lead engagements. Few businesses buy technology without a clear understanding of the business case and full transparency of the cost-of-ownership around their technology investments - Applicaster understands this and provides flexible commercial models that scale and can easily be upgraded and expanded as business requirements evolv

Clovis Oncology Announces Reimbursement for Rubraca® (rucaparib) Tablets for Women with Relapsed Ovarian Cancer in Italy13.11.2019 09:00:00 CETPress release

Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the Italian Medicines Agency (AIFA) has approved rucaparib for reimbursement in Italy. Rucaparib will soon be available as an option for monotherapy maintenance treatment for adults with relapsed, platinum-sensitive high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer that has responded to platinum-based chemotherapy.3 Rucaparib is indicated for eligible patients regardless of BRCA status, which means it can be prescribed for women who harbor a BRCA mutation or who are BRCA wild-type.3 “We very much welcome the arrival of the PARP inhibitor rucaparib, which offers a new treatment option after surgery and two lines of chemotherapy to all eligible women affected by relapsed ovarian cancer,” declared Nicoletta Cerana, National President of Acto Onlus, the number one Italian network of patient associations involved in the fight against ovarian cancer and gynecological tumors. “Ovarian cancer is a highly lethal

Traxens Presents Solutions for Port Industry at Smart Ports Barcelona13.11.2019 07:30:00 CETPress release

Traxens, a company providing high-value data and services for the supply chain industry, announces today that it will present its smart asset tracking solutions at the Smart Ports Barcelona event, Smart Ports, Piers of the Future, November 19 to 21. Its tailored Industrial Internet of Things (IIoT) solutions are specifically designed to meet the needs of the port industry by providing near real-time insight into the end-to-end global supply chain. Traxens’ solution provides comprehensive, precise and timely data on cargo, through tracking logistic assets in transit anywhere in the world. Traxens’ patented breakthrough Internet of Things (IoT) technology brings improved efficiency and security, greater transparency and enhanced asset utilization whilst opening up new opportunities for all actors involved in the global supply chain. With Traxens’ solutions, ports can improve their efficiency and the interoperability of the systems with a trusted third party. For example, the Cargo Commun

PMC Group Announces Agreement to Acquire Lanxess’ Organotin Specialties Business13.11.2019 06:30:00 CETPress release

PMC Group N.A., Inc. ("PMC") and Lanxess Organometallics GmbH are pleased to announce that the parties have reached an agreement whereby PMC’s European subsidiary will acquire the organotin specialties product line (the “Business”) from Lanxess. The transaction is scheduled to close by year end, subject to customary closing conditions. The Business includes Lanxess’ global organotin catalyst, organotin specialties and intermediates product lines. The transaction includes a toll manufacturing agreement under which Lanxess will continue to manufacture certain products post-closing for PMC at its Bergkamen, Germany organometallics manufacturing facility. Mr. Debtosh Chakrabarti, President of PMC said, “This acquisition represents PMC’s continuing commitment to the organotin industry and is synergistic to our existing organometallics and catalyst businesses. We believe that the customer base of the Business as well as all of PMC’s customers will benefit significantly from combining the tec